These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9498764
21. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity. Kosaka A, Wakita D, Matsubara N, Togashi Y, Nishimura S, Kitamura H, Nishimura T. Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818 [Abstract] [Full Text] [Related]
22. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Ahn JS, Krishnadas DK, Agrawal B. Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657 [Abstract] [Full Text] [Related]
23. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2. Harthun NL, Weaver AM, Brinckerhoff LH, Deacon DH, Gonias SL, Slingluff CL. J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359 [Abstract] [Full Text] [Related]
24. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. Sepulveda H, Cerwenka A, Morgan T, Dutton RW. J Immunol; 1999 Aug 01; 163(3):1133-42. PubMed ID: 10415007 [Abstract] [Full Text] [Related]
25. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS. J Clin Invest; 1998 Jul 01; 102(1):223-31. PubMed ID: 9649576 [Abstract] [Full Text] [Related]
26. Augmentation of NK cell activity and proliferation in cultured lymphocytes of leukemic patients by monoclonal antibodies CD3 and interleukin-2. Soucek J, Hilgert I, Budová I, Lindnerová G. Neoplasma; 1994 Jul 01; 41(2):75-81. PubMed ID: 8208318 [Abstract] [Full Text] [Related]
27. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW, Liao CH, Ying C, Chang CJ, Lin CM. Clin Immunol; 2006 Apr 01; 119(1):21-31. PubMed ID: 16406844 [Abstract] [Full Text] [Related]
28. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse. Watson CL, Furlong SJ, Hoskin DW. Immunol Invest; 2008 Apr 01; 37(1):63-78. PubMed ID: 18214800 [Abstract] [Full Text] [Related]
29. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis. Yotsukura J, Huang H, Singh AK, Shichi H. Cell Immunol; 1997 Dec 15; 182(2):89-98. PubMed ID: 9514702 [Abstract] [Full Text] [Related]
30. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro. Iho S, Yamamoto T, Takahashi T, Yamamoto S. J Immunol; 1999 Oct 01; 163(7):3642-52. PubMed ID: 10490958 [Abstract] [Full Text] [Related]
31. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors. Tanaka J, Toubai T, Miura Y, Tsutsumi Y, Kato N, Umehara S, Toyoshima N, Ohta S, Asaka M, Imamura M. Transplant Proc; 2004 Oct 01; 36(8):2511-2. PubMed ID: 15561299 [Abstract] [Full Text] [Related]
33. CD2 and other surface molecules in the regulation of non-MHC-restricted cytolytic function. Chan WC, Ye G, Link S, Mawle AC, Nicholson JK. Immunology; 1989 May 01; 67(1):56-61. PubMed ID: 2567703 [Abstract] [Full Text] [Related]
34. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Falco M, Marcenaro E, Romeo E, Bellora F, Marras D, Vély F, Ferracci G, Moretta L, Moretta A, Bottino C. Eur J Immunol; 2004 Jun 01; 34(6):1663-72. PubMed ID: 15162436 [Abstract] [Full Text] [Related]
35. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells. Tomura M, Zhou XY, Maruo S, Ahn HJ, Hamaoka T, Okamura H, Nakanishi K, Tanimoto T, Kurimoto M, Fujiwara H. J Immunol; 1998 May 15; 160(10):4738-46. PubMed ID: 9590219 [Abstract] [Full Text] [Related]
36. Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibody. Tutt AL, Reid R, Wilkins BS, Glennie MJ. J Immunol; 1995 Sep 15; 155(6):2960-71. PubMed ID: 7673714 [Abstract] [Full Text] [Related]
38. Suppression of natural killer cell differentiation by activated T lymphocytes in long-term cultures of mouse bone marrow. Delfino DV, Lepri E, Ayroldi E, Migliorati G, Boggs SS, Riccardi C. Exp Hematol; 1998 Jan 15; 26(1):2-9. PubMed ID: 9430508 [Abstract] [Full Text] [Related]
40. Some combinations of anti-CD2 MAb induce apoptosis of activated CD8+/CD57+ T cells. Rouleau M, Bernard A, Lantz O, Vernant JP, Charpentier B, Senik A. Transplant Proc; 1995 Feb 15; 27(1):1431-3. PubMed ID: 7533385 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]